Abbott Ventures

Abbott Ventures is the corporate venture capital arm of Abbott Laboratories, the global healthcare company, founded in 2004 and based in Abbott Park, Illinois. The firm focuses exclusively on emerging medical technologies including medical devices, diagnostics, drug delivery, and drug-device combinations that align with Abbott's strategic priorities across its core healthcare businesses. Unlike independent VC funds, Abbott Ventures targets investments where it sees the largest impact on Abbott's medical device divisions and can simultaneously create shareholder value while improving patient outcomes. Typical deal sizes range from $10 million to $50 million at Series B and later stages. The portfolio of 18 investments includes Bigfoot Biomedical, a diabetes management technology company, and Direct Flow Medical, which focused on structural heart disease — both reflecting Abbott's deep medical device and diagnostics expertise. Additional portfolio companies span the spectrum of medical technology, from monitoring equipment to therapeutic devices. Abbott Ventures provides portfolio companies with access to Abbott's global healthcare infrastructure: regulatory expertise built across decades of FDA and international approvals, clinical networks spanning hospitals and health systems worldwide, and commercial distribution channels reaching patients in more than 160 countries. This strategic positioning makes Abbott Ventures a particularly valuable partner for medical technology companies seeking both capital and an accelerated path to clinical adoption and commercial scale in the competitive medical devices market.